Discovery and characterization of novel allosteric FAK inhibitors

被引:43
|
作者
Iwatani, Misa [1 ]
Iwata, Hidehisa [1 ]
Okabe, Atsutoshi [1 ]
Skene, Robert J. [2 ]
Tomita, Naoki [1 ]
Hayashi, Yoko [1 ]
Aramaki, Yoshio [1 ]
Hosfield, David J. [2 ]
Hori, Akira [1 ]
Baba, Atsuo [1 ]
Miki, Hiroshi [1 ]
机构
[1] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa 2518555, Japan
[2] Takeda Calif, San Diego, CA 92121 USA
关键词
Focal adhesion kinase; Allosteric inhibitor; Slow dissociation; Cancer; FOCAL-ADHESION KINASE; TYROSINE KINASE; PROTEIN-KINASES; STRUCTURAL BASIS; MAP KINASE; BINDING; CANCER; EXPRESSION; PHOSPHORYLATION; CONFORMATION;
D O I
10.1016/j.ejmech.2012.06.035
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Focal adhesion kinase (FAR) regulates cell survival and proliferation pathways. Here we report the discovery of a highly selective series of 1,5-dihydropyrazolo[4,3-c][2,1]benzothiazines that demonstrate a novel mode of allosteric inhibition of FAR. These compounds showed slow dissociation from unphosphorylated FAR and were noncompetitive with ATP after long preincubation. Co-crystal structural analysis revealed that the compounds target a novel allosteric site within the C-lobe of the kinase domain, which induces disruption of ATP pocket formation leading to the inhibition of kinase activity. The potency of allosteric inhibition was reduced by phosphorylation of FAR. Coupled SAR analysis revealed that N-substitution of the fused pyrazole is critical to achieve allosteric binding and high selectivity among kinases. (C) 2012 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:49 / 60
页数:12
相关论文
共 50 条
  • [1] Fragment based drug discovery of allosteric FAK inhibitors
    Cossio, Osvaldo
    Campos-Olivas, Ramon
    Santiveri Martin-Vares, Clara
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [2] Structure-based discovery of cellular-active allosteric inhibitors of FAK
    Tomita, Naoki
    Hayashi, Yoko
    Suzuki, Shinkichi
    Oomori, Yoshimasa
    Aramaki, Yoshio
    Matsushita, Yoshihiro
    Iwatani, Misa
    Iwata, Hidehisa
    Okabe, Atsutoshi
    Awazu, Yoshiko
    Isono, Osamu
    Skene, Robert J.
    Hosfield, David J.
    Miki, Hiroshi
    Kawamoto, Tomohiro
    Hori, Akira
    Baba, Atsuo
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (06) : 1779 - 1785
  • [3] Discovery and Characterization of Allosteric WNK Kinase Inhibitors
    Yamada, Ken
    Zhang, Ji-Hu
    Xie, Xiaoling
    Reinhardt, Juergen
    Xie, Amy Qiongshu
    LaSala, Daniel
    Kohls, Darcy
    Yowe, David
    Burdick, Debra
    Yoshisue, Hajime
    Wakai, Hiromichi
    Schmidt, Isabel
    Gunawan, Jason
    Yasoshima, Kayo
    Yue, Q. Kimberley
    Kato, Mitsunori
    Mogi, Muneto
    Idamakanti, Neeraja
    Kreder, Natasha
    Drueckes, Peter
    Pandey, Pramod
    Kawanami, Toshio
    Huang, Waanjeng
    Yagi, Yukiko I.
    Deng, Zhan
    Park, Hyi-Man
    [J]. ACS CHEMICAL BIOLOGY, 2016, 11 (12) : 3338 - 3346
  • [4] Discovery of Novel Allosteric Inhibitors of Deoxyhypusine Synthase
    Tanaka, Yuta
    Kurasawa, Osamu
    Yokota, Akihiro
    Klein, Michael G.
    Ono, Koji
    Saito, Bunnai
    Matsumoto, Shigemitsu
    Okaniwa, Masanori
    Ambrus-Aikelin, Geza
    Morishita, Daisuke
    Kitazawa, Satoshi
    Uchiyama, Noriko
    Ogawa, Kazumasa
    Kimura, Hiromichi
    Imamura, Shinichi
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (06) : 3215 - 3226
  • [5] Discovery and optimization of novel pyrazolopyrimidines as allosteric integrase inhibitors
    Pendri, Annapurna
    Li, Guo
    Walker, Michael
    Naidu, B. Narasimhulu
    Langley, David
    Lewis, Hal
    Ng, Alicia
    Trainor, George
    Dicker, Ira
    Cianci, Christopher
    Krystal, Mark
    Lin, Zeyu
    Protack, Tricia
    Discotto, Linda
    Minassian, Beatrice
    Jenkins, Susan
    Meanwell, Nicholas
    Gerritz, Sam
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [6] Discovery and characterization of novel allosteric modulators of GPCRs
    Conn, Jeff
    Weaver, David
    Niswender, Colleen
    Brady, Ashley
    Shirey, Jana
    Edl, Jenifer
    [J]. NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S65 - S65
  • [7] Novel targets in oncology: Discovery of novel allosteric inhibitors of IRE1α
    Evans, Karen A.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [8] Discovery of arylsulfonamides as a novel class of allosteric integrase inhibitors with antiviral activity
    Wang, Cheng
    Adam, Gregory C.
    Burlein, Christine
    Carroll, Steven
    Dankulich, William
    Diamond, Tracy
    Grobler, Jay
    Heath, Jeffrey
    Johnson, Adam
    Klein, Daniel
    Krosky, Daniel
    Narayan, Kartik
    Ou, Yangsi
    Sanders, John
    Sharma, Sujata
    Xu, Min
    Converso, Antonella
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 89
  • [9] Discovery of a Novel Series of Potent SHP2 Allosteric Inhibitors
    Petrocchi, Alessia
    Grillo, Alessandro
    Ferrante, Luca
    Randazzo, Pietro
    Prandi, Adolfo
    De Matteo, Marilenia
    Iaccarino, Costanza
    Bisbocci, Monica
    Cellucci, Antonella
    Alli, Cristina
    Nibbio, Martina
    Pucci, Vincenzo
    Amaudrut, Jerome
    Montalbetti, Christian
    Toniatti, Carlo
    Di Fabio, Romano
    [J]. ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (05): : 645 - 651
  • [10] Discovery of novel and highly selective allosteric inhibitors of PAK1
    Lindvall, Mika
    Karpov, Alexei
    Bellamacina, Cornelia
    Daniel, Dylan
    Fabbro, Doriano
    Fernandez, Cesar
    Jacob, Sandra
    Jahnke, Wolfgang
    Moebitz, Henrik
    Pecchi, Sabina
    Pecchi, Sabina
    Shoemaker, Kevin
    Wang, John
    Breitenstein, Werner
    Gutmann, Sascha
    Lagasse, Stephanie
    Machajewski, Timothy
    Marzinzik, Andreas
    Galuba, Inga
    Trappe, Joerg
    Crawford, Kenneth
    Voliva, Charles
    Lai, Albert
    Hinh, Linda
    Rummel, Gabriele
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246